Market revenue in 2023 | USD 14.8 million |
Market revenue in 2030 | USD 23.9 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Biomarker services |
Fastest growing segment | Genetic Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.51% in 2023. Horizon Databook has segmented the Argentina central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
Substantial government support for clinical research coupled with improvements in healthcare infrastructure is anticipated to propel market growth.
The country has become a prime destination for outsourcing clinical research and central laboratory services due to several advantages offered, such as relatively easy access to the patient population and the presence of one of the most developed healthcare systems in Latin America.
As a result, the demand for central laboratory services in Argentina is expected to grow in the near future. Clinical trials in the country are majorly regulated by the National Administration of Drugs, Foods and Medical Technology (ANMAT), under the Argentine Ministry of Health, in addition to other local regulatory bodies.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina central lab market , including forecasts for subscribers. This country databook contains high-level insights into Argentina central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account